Snoezelen® is a therapeutic approach that uses multisensory experiences. It was developed in the Netherlands in the 1970s for people with developmental disabilities.

Apart from the drugs, some other therapies have proved successful to slow the onset of Alzheimer's symptoms.

The Geriatric Psychiatry Program at the Douglas Institute provides services to clients aged 65 and older and to adults younger than 65 with a geriatric profile. The program covers psychiatric diagnoses such as: mood disorders anxiety di